drugset / Trial / NCT04151329
A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor
SequentialOpen-labelTreatment
Summary
A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With HER2-positive Advanced Solid Tumor
Timeline
- Start
- 2019-06-21
- Primary completion
- 2020-12-31
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAT8001 | Monoclonal antibody | 2.4 mg/kg | Intravenous |
| Subject | BAT8001 | Monoclonal antibody | 3.6 mg/kg | Intravenous |
| Background | BAT1306 | Unknown | 200 mg | Intravenous |